Press

Acarix Q2 2024 video presentation

22 Aug

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, held a live presentation of the second-quarter results today Thursday, August 22, 2024. The video presentation is now available on Penser Play youtube channel.

Acarix held a live presentation of the second-quarter results on Thursday, August 22, 2024. The video presentation is now available on Penser Play youtube channel.

The presentation feature Aamir Mahmood, Acarix CEO, that presented the second-quarter results and was concluded with a Q&A session held by Carnegie analyst, Ludvig Svensson. The video presentation is available at: https://youtu.be/8_y0a3N7Ayc

For more information contact:
Jennifer Anderson, Head of Marketing & Communications, phone +1 720 471 4625, email [email protected] 

About Acarix

Acarix is a Swedish medical device company that innovates solutions for rapid rule out of coronary artery disease (CAD) at point of care. The CE-approved and FDA DeNovo-cleared Acarix CADScor System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive, and costly diagnostic procedures. The CADScor System has been used on more than 29,000 patients. Acarix recommends CADScor System as a first-line diagnostic aid that uses highly sensitive acoustics and advanced computational processing to analyze coronary blood flow to rule out significant coronary artery disease (CAD), with at least 96% certainty at point of care. Acarix is listed on the Nasdaq First North Premier Growth Market in Stockholm (ticker: ACARIX) and cross-traded on the OTCQB market in the US (ticker: ACIXF). Carnegie Investment Bank is the Certified Advisor of Acarix. For more information, please visit www.acarix.com

Attachments
Acarix Q2 2024 video presentation

Tags:
,
Newer Acarix receives declarations of intent to exercise warrants of series TO 3
Back to list
Older Acarix AB (publ) publishes Interim Report, April – June 2024

Related Posts